Fulcrum Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:FULC) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities -19.07 M-12.32 M15.26 M13.82 M14.19 M16.8 M 60.06 M Cash from investing activities 4.35 M2.26 M777 K12.38 M18.61 M-1.05 M 30.72 M Cash from financing activities 635 K83 K0301 K64 K168.3 M 168.67 M Free cash flow -19.09 M-12.56 M15.26 M13.76 M14.1 M16.64 M 59.75 M

뉴스

Fulcrum: Strong HbF Signal, Narrow TAM, Same 'Hold' Conclusion (NASDAQ:FULC)

풀크럼 테라퓨틱스, 겸상 적혈구 임상 시험 목표 미달로 주가 하락

Fulcrum Therapeutics stock falls as sickle cell trial misses target

리어링크, 겸상 적혈구병 데이터에 풀크럼 테라퓨틱스 투자의견 재확인

Leerink reiterates Fulcrum Therapeutics stock rating on SCD data

BofA, 풀크럼 테라퓨틱스에 ’저조한 실적’ 투자의견 유지, 목표가 7달러

BofA reiterates Fulcrum Therapeutics stock Underperform rating at $7

스티펠, Fulcrum Therapeutics에 ’매수’ 등급 재확인

Stifel reiterates Fulcrum Therapeutics stock rating on drug data

풀크럼 테라퓨틱스, 차익 실현 매물에 하락…오펜하이머 분석

Fulcrum Therapeutics shares fall on profit-taking, Oppenheimer says

풀크럼 테라퓨틱스, 임상 결과에도 주가 급락